1. Home
  2. PTN

PTN

Palatin Technologies Inc.

Logo Palatin Technologies Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.

Founded: 1986 Country:
United States
United States
Employees: N/A City: CRANBURY
Market Cap: 30.2M IPO Year: 1993
Target Price: $17.00 AVG Volume (30 days): 723.5K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.61 EPS Growth: N/A
52 Week Low/High: $1.43 - $5.65 Next Earning Date: 05-14-2024
Revenue: $7,097,698 Revenue Growth: 146.20%
Revenue Growth (this year): -10.62% Revenue Growth (next year): 74.14%

Share on Social Networks: